EnSilica PLCLSE: ENSI

EnSilica: Grant of Options

· Issued by EnSilica PLC

Summary by 6ix AI

EnSilica, a UK-based chip designer listed on AIM (the London Stock Exchange's growth market), had its Remuneration Committee approve option grants over ordinary shares to its executive directors and senior managers under its Long Term Incentive Plan 2022, with 2,166,000 of the options going to the three executive directors.

Key details

  • On July 16, 2026, Chairman Mark Hodgkins received 393,000 options (1,908,000 now held), CEO Ian Lankshear 1,212,000 (4,227,000 now held) and CFO Kristoff Rademan 561,000 (689,625 now held).
  • Each option has an exercise price of 0.1p per share, the shares' nominal value. Half of any shares acquired on exercise must be held for one year (net of applicable tax).
  • Half the options depend on adjusted EBITDA (earnings before interest, tax, depreciation and amortisation): 25% of these vest at £10.0 million for the year ending May 31, 2029 (£12.0 million for the year ending May 31, 2030), and all vest at £13.0 million (or £15.0 million).
  • Half depend on total shareholder return, measured by the average share price over 20 trading days after annual results: 25% of these vest at 150 pence at the year ending May 31, 2029 test (172 pence at the 2030 test), and all vest at 200 pence (252 pence). Vesting rises in a straight line from 25% to 100% between the thresholds.
  • There are now a total of 10,188,526 options over new ordinary shares granted to EnSilica's directors and employees.

What’s still pending

  • The options ordinarily vest after results for the year ending May 31, 2029 are announced, subject to, among other things, the performance conditions and continued employment.
  • If the threshold targets are not met at the first test, the options can still vest after results for the year ending May 31, 2030, subject to higher targets.
  • The options are subject to the customary provisions of the plan, including malus and clawback (reduction or recovery of awards), leaver provisions and the Remuneration Committee's discretion in appropriate circumstances.

6ix AI wrote this summary from the release below and checked it against the release.

17 July 2026

EnSilica plc

("EnSilica" or the "Company")

Grant of options to executive directors and management

EnSilica (AIM: ENSI), a leading fabless microchip maker with a growing portfolio of reusable IP, serving the Space and Communications, Industrial, and Automotive markets, announces that the Company's Remuneration Committee has approved the grant of options over ordinary shares of 0.1p each in the Company ("Ordinary Shares") under the Company's Long Term Incentive Plan 2022 (the "LTIP") to the Company's Executive Directors and members of the senior management team (the "Options").

The Options are intended to align the interests of the Company's Executive Directors and members of the senior management team with those of shareholders by incentivising the delivery of sustained long-term growth in earnings and shareholder value.

In addition to the Options, the board of directors of EnSilica (the "Board" or the "Directors") will continue to grant equity awards to key employees under its broader employee incentive arrangements. The Board believes that broad employee participation in equity incentive schemes helps align employees' interests with those of shareholders and supports the attraction, motivation and retention of skilled talent across the business.

Further details of the Options

The Options will ordinarily vest following the announcement of the Company's results for the financial year ending 31 May 2029 ("FY2029"), subject to, inter alia, the achievement of demanding performance conditions and continued employment. Where the threshold performance conditions are not achieved at the initial three-year testing date, the Options will remain capable of vesting following the announcement of the Company's results for the financial year ending 31 May 2030 ("FY2030"), subject to the achievement of higher performance targets.

Performance will be measured equally against two independent metrics:

1)   EBITDA - 50% of the Options are based on adjusted EBITDA targets, whereby 25% of these Options will vest when underlying adjusted EBITDA reaches £10.0 million for FY2029 (increasing to £12.0 million at the FY2030 testing date), with full vesting of these Options requiring adjusted EBITDA of £13.0 million for FY2029 (or £15.0 million for FY2030); and

2)   Total Shareholder Return ("TSR") - 50% of the Options are based on TSR targets, measured by reference to the Company's average share price over the 20 trading days from the announcement of the relevant annual results. Vesting will commence as to 25% of these Options only if the average share price reaches 150 pence at the FY2029 testing date (or 172 pence at the FY2030 testing date), with full vesting of these Options requiring an average share price of 200 pence for the FY2029 testing date (or 252 pence for the FY2030 testing date).

Between the minimum and maximum performance thresholds, vesting of the Options will occur on a straight-line basis from 25% to 100%.

In addition, for any Options that vest and are exercised, 50% of the shares acquired will be subject to a mandatory one-year holding period (net of applicable tax liabilities), further reinforcing the alignment of management's interests with those of shareholders over the longer term.

Pursuant to the terms of the LTIP, each Option has an exercise price of 0.1p per share, being the nominal value of the Company's ordinary shares.

The Options are subject to the customary provisions of the LTIP, including malus and clawback, leaver provisions and the discretion of the Remuneration Committee in appropriate circumstances.

Executive Director Options

Of the Options granted, 2,166,000 have been granted to the Executive Directors of the Company as set out below:

Name

Role

Number of new Options granted

Number of existing options held

Total number of options now held

Mark Hodgkins

Chairman

393,000

1,515,000

1,908,000

Ian Lankshear

Chief Executive Officer

1,212,000

3,015,000

4,227,000

Kristoff Rademan

Chief Financial Officer

561,000

128,625

689,625

The table at the end of this announcement, which is provided in accordance with the requirements of the UK Market Abuse Regulation, provides further details.

There is now a total of 10,188,526 options over new Ordinary Shares granted to directors and employees of the Company.

For further information please contact:

EnSilica plc

Ian Lankshear, Chief Executive Officer

Kristoff Rademan, Chief Financial Officer

www.ensilica.com

via Novella Communications

+44 (0)20 3151 7008

Allenby Capital Limited (Nominated Adviser & Joint Broker)

Jeremy Porter / Vivek Bhardwaj (Corporate Finance)

Joscelin Pinnington / Tony Quirke (Sales & Corporate Broking)

+44 (0)20 3328 5656

info@allenbycapital.com

Panmure Liberum Limited (Joint Broker)

Edward Mansfield / Will King / Zak Wadud (Corporate Finance)

Rupert Dearden / Rauf Munir (Corporate Broking)

+44 (0)20 3100 2000

Novella Communications (Investor & Financial Public Relations)

Tim Robertson / Oliver Norton

+44 (0)20 3151 7008

ensilica@novella-comms.com

About EnSilica plc

EnSilica is a fabless, application-specific chipmaker, combining deep domain and system-level expertise with world-class capability in RF, mmWave, mixed-signal and complex digital IC design. The Company serves customers across the space and communications, industrial, and automotive markets, where safety, security and reliability are critical.

A growing portfolio of reusable IP and silicon platforms underpins a repeatable, scalable delivery model, reducing development risk, cost and time to market while supporting long-term supply revenues. EnSilica has a strong track record of delivering production-proven silicon to demanding industry standards. Headquartered near Oxford, UK, the Company operates design centres across the UK, India, Brazil and Hungary.

LEI: 213800R6VXRU7MJTAF04

Information required under the UK Market Abuse Regulation:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Hodgkins

Chairman

Ian Lankshear

Chief Executive Officer

Kristoff Rademan

Chief Financial Officer

2

Reason for the notification

a)

Position/status

See 1(a) above

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

EnSilica plc

b)

LEI

213800R6VXRU7MJTAF04

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.1p each in EnSilica plc ("Ordinary Shares")

ISIN: GB00BN7F1618

b)

Nature of the transaction

Grant of options over Ordinary Shares under the EnSilica plc Long Term Incentive Plan 2022

c)

Price(s) and volume(s)

Name

Volume

Exercise price

Mark Hodgkins

393,000

0.1 pence

Ian Lankshear

1,212,000

0.1 pence

Kristoff Rademan

561,000

0.1 pence

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

16 July 2026

f)

Place of the transaction

Outside of a trading venue

EnSilica PLC on 6ix

Story so far

Earlier from EnSilica

Later from EnSilica

All EnSilica news releases